The availability of inhaled human insulin (Exubera) may lead to a great acceptance of insulin therapy in Euopean type 2 diabetes patients failing on diet and/ or oral agent therapy

Nick Freemantle, L Blonde, Frederick Hobbs, M Kvasz, N Marchant, SA Ross

    Research output: Contribution to journalArticle

    Original languageEnglish
    JournalEASD Copenhagen 14th September 2006
    Publication statusPublished - 1 Jan 2007

    Cite this